Vital Signs - RFID in Pharma - Achieving Supply Chain Efficiencies

 

Regular Price: USD 1,500.00

Special Price USD 1,050.00

30% OFF

* Required Fields

Regular Price: USD 1,500.00

Special Price USD 1,050.00

PAY BY INVOICE

Be the first to review this product

This issue of Vital Signs, released on October 30, 2006, provides a strategic overview of the application of radio frequency identification (RFID) in pharmaceutical supply chain management. Additionally, an emerging company profile is provided for Surface Logix, Inc., a drug development company that utilizes proprietary biophysical chemistry for the development of NCEs with improved PK/PD profiles. Reimbursement and regulatory news from the FDA and CMS is also provided for the week of October 16 - October 20, 2006.

Table of Contents

Vital Signs - RFID in Pharma - Achieving Supply Chain EfficienciesVital Signs: 30 October 2006This week's issue:




Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.